Wessely's War

Of all the job titles Simon Wessely thought he might hold in his life, researcher ranked among the least likely. He wanted to be a physician. "I certainly didn't see myself in a laboratory," Wessely says. So the Sheffield, England native collected the necessary degrees, but wasn't in practice long before he realized he found general medicine unchallenging. Wessely moved on to psychiatry and in time found his true niche. In one of life's delicious little twists, Wessely is today considered one o

Written byBob Calandra
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

In one of life's delicious little twists, Wessely is today considered one of the leading researchers on Gulf War syndrome. His studies on scores of veterans reveal that fighting in the Gulf did affect their health, causing still undefined ailments, and that multiple vaccinations play at least a small role in their infirmities. His findings have forced governments and the medical community to re-evaluate treatment of Gulf War veterans. "We haven't found the smoking gun and I don't think we will," says Wessely, psychiatric epidemiologist and head of general hospital psychiatry at London's Institute of Psychiatry. "But we have shown beyond a shadow of a doubt that something has happened and attention must be paid. It's not aberration or media frenzy."

Wessely asserts that no single solution can explain illnesses like Gulf War syndrome, and his multidisciplinary team of researchers includes a war historian, who compares the syndrome with illnesses ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies